P-007

PCP (Phencyclidine) solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• 동의어(들): Phencyclidine
• 실험식(Hill 표기법): C₁₇H₂₅N
• CAS Number: 77-10-1
• Molecular Weight: 243.39
• MDL number: MFCD00055598
• UNSPSC 코드: 41116107
• PubChem Substance ID: 329820005
• NACRES: NA.24

속성

• Grade: certified reference material
• 형태: liquid
• 특징: Snap-N-Spike^®/Snap-N-Shoot^®
• 포장: ampule of 1 mL
• 제조업체/상표: Cerilliant^®
• drug control: Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIA (Portugal)
• 농도: 1.0 mg/mL in methanol
• 기술: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 응용 분야: forensics and toxicology
• 형식: single component solution
• 저장 온도: 2-8°C
• InChI: 1S/C17H25N/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18/h1,4-5,10-11H,2-3,6-9,12-15H2
• InChI key: JTJMJGYZQZDUJJ-UHFFFAOYSA-N

설명

일반 설명

Phencyclidine, commonly known as PCP, is a recreational drug with hallucinogenic and neurotoxic effects. With street names such as "angel dust" or "wet", PCP comes in either powder or liquid forms. The illicit drug is typically sprayed onto leafy material such as cannabis and then smoked. This certified solution standard is suitable for use as starting material in calibrators and controls for a variety of LC/MS or GC/MS applications from forensic analysis and clinical toxicology to urine drug testing.

Phencyclidine, commonly known as PCP, is a recreational drug with hallucinogenic and neurotoxic effects. With street names such as "angel dust" or "wet", PCP comes in either powder or liquid forms. The illicit drug is typically sprayed onto leafy material such as cannabis and then smoked. This certified solution standard is suitable for use as starting material in calibrators and controls for a variety of LC/MS or GC/MS applications from forensic analysis and clinical toxicology to urine drug testing.

애플리케이션

• A Collaborative Platform for Novel Compound Identification - Characterization of Designer Phencyclidines (PCPs) POXP, PTHP, and P2AP: This research highlights a collaborative platform for the identification and characterization of novel designer PCPs, emphasizing their potential as analytical standards and sigma receptor agonists. The study provides valuable insights for scientists involved in receptor binding studies and the development of dissociative anesthetics for research (Sisco, Urbas, 2023).


• Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction: Investigating the long-term effects of NMDAR hypofunction in mice, this study uses PCP to elucidate mechanisms of schizophrenia, showcasing its application as a NMDA receptor antagonist in neuropharmacological studies. The findings are crucial for advancing knowledge on neurotransmitter research and mental health disorders (Ponserre et al., 2024).


• 3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an (18)F-FDG PET/CT Case Report: This review and case report discuss the psychiatric implications of 3-Methoxy-Phencyclidine, a derivative of PCP, providing insights into its effects on human cognition and behavior. Such studies are essential for developing high-purity PCP liquids for sigma receptor assays and understanding its role as a non-competitive NMDA antagonist (Pepe et al., 2024).


• Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens: This review explores the dermatological reactions associated with psychedelic drugs, including PCP. It underscores the importance of understanding the biochemical pathways affected by PCP, reinforcing its utility as a research chemical in pharmaceutical applications (Rahman et al., 2024).


• Novel α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) potentiator LT-102: A promising therapeutic agent for treating cognitive impairment associated with schizophrenia: This research explores the potential therapeutic uses of AMPAR potentiators, highlighting PCP′s role in enhancing understanding of glutamatergic dysfunction in schizophrenia. It showcases PCP′s utility in developing treatments that modulate neurotransmitter systems, valuable for neuropharmacology research (Qi et al., 2024).

법적 정보

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

안전성 정보

• 픽토그램: GHS02,GHS06,GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H225,H301 + H311 + H331,H370
• 예방조치 성명서: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 표적 기관: Eyes,Central nervous system
• Storage Class Code: 3 - Flammable liquids
• WGK: WGK 2
• Flash Point (°F): 49.5 °F - closed cup
• Flash Point (°C): 9.7 °C - closed cup